Test Bank NURS 6630 Midterm Exam (2025) comprehensive questions a
verified answers ( detailed & elaborated) ACTUAL EXAM 2025 TEST!!
Study online at https://quizlet.com/_gphkbe
1. Patient refusal to follow prescribed treatment.: Noncompliance
2. Disruption in brain chemical levels affecting mood.: Neurotransmitter Imbalance
3. Symptoms that add to the patient's experience.: Positive Symptoms
4. Increased restlessness or anxiety in schizophrenia.: Agitation
5. Neurotransmitter linked to mood regulation.: Serotonin
6. First antidepressant targeting serotonin imbalance.: Prozac
7. Impaired neurotransmitter functions in psychiatric illnesses.: Dysfunctioning Neuro-
transmitter Systems
8. Process of converting genetic information into proteins.: Gene Expression
9. Protein that initiates gene transcription.: Transcription Factor
10. Changes in behavior influencing genetic expression.: Behavior Modification
11. Enzyme system affecting drug metabolism.: Cytochrome P450
12. Amount of drug available after metabolism.: Bioavailability
13. Study of drug absorption, distribution, metabolism, and excretion.: Pharmaco-
kinetics
14. Some Asians require reduced doses of medications.: Lower Drug Doses
15. Receptors that mediate cellular responses to neurotransmitters.: G-Protein Linked
Receptors
16. Medications that block receptor activity.: Antagonistic Traits
17. Medication used for treatment-resistant schizophrenia.: Clozapine (Clozaril)
18. Smoking can alter medication metabolism.: Smoking Impact
19. Mood stabilizer associated with thrombocytopenia.: Carbamazepine (Tegretol)
20. Medication used to treat mood disorders.: Mood Stabilizer
21. Antidepressant also used for chronic pain.: Amitriptyline (Elavil)
22. SSRI antidepressant for depression and anxiety.: Fluoxetine (Prozac)
23. Low platelet count caused by medication.: Drug-Induced Thrombocytopenia
24. An antidepressant used for mood disorders.: Amitriptyline (Elavil)
25. Decreases serotonin and dopamine activity.: Inverse agonist
26. Medications for anxiety and panic disorders.: Benzodiazepines
27. Receptors that mediate rapid synaptic transmission.: Ionotropic receptors
28. Medication used for smoking cessation.: Varenicline (Chantix)
, Test Bank NURS 6630 Midterm Exam (2025) comprehensive questions a
verified answers ( detailed & elaborated) ACTUAL EXAM 2025 TEST!!
Study online at https://quizlet.com/_gphkbe
29. Drugs that partially stimulate receptors.: Partial agonists
30. Medications used to stabilize mood and treat seizures.: Anticonvulsants
31. Channels activated by neurotransmitter binding.: Ligand-gated ion channels
32. An SSRI used to treat panic disorder.: Sertraline
33. Used temporarily to manage anxiety symptoms.: Short-acting benzodiazepine
34. Medications that prevent mood swings in bipolar disorder.: Mood stabilizers
35. Antidepressants with significant food interactions.: MAO inhibitors
36. An SSRI with uncommon sedation side effects.: Fluoxetine
37. Signs of elevated mood and hyperactivity.: Manic symptoms
38. Dopamine receptors targeted by antipsychotics.: D2 receptors
39. Involuntary movements from long-term antipsychotic use.: Tardive dyskinesia
40. Severe increase in blood pressure from food interactions.: Hypertensive crisis
41. Receptors involved in serotonin signaling.: Serotonin 3 receptors
42. Cholinergic receptors that respond to acetylcholine.: Nicotinic receptors
43. Receptors activated by the neurotransmitter acetylcholine.: Cholinergic receptors
44. Inhibitory receptors in the central nervous system.: Glycine receptors
45. Stimulates dopamine receptors to treat Parkinson's disease.: Dopamine agonist
46. Primary binding site for dopamine agonists.: D2 Receptors
47. Pathways influencing cognitive symptoms in schizophrenia.: Mesocorticol Projec-
tions
48. Antidepressant with rare induction of mania.: Fluoxetine
49. Medications requiring avoidance of certain decongestants.: MAO Inhibitors
50. Severe increase in blood pressure from drug interactions.: Hypertensive Crisis
51. Symptoms persisting despite treatment for major depression.: Residual Symptoms
52. Influences response to SSRIs and SNRIs.: SERT Genotype
53. Inability to feel pleasure, common in depression.: Anhedonia
54. Considered a positive symptom of schizophrenia.: Agitation
55. Requires antipsychotics targeting specific symptoms.: Paranoid Psychosis
56. Theory explaining schizophrenia symptoms via dopamine pathways.: Dopamine
Hypothesis
57. Syndrome associated with various psychiatric disorders.: Psychosis
, Test Bank NURS 6630 Midterm Exam (2025) comprehensive questions a
verified answers ( detailed & elaborated) ACTUAL EXAM 2025 TEST!!
Study online at https://quizlet.com/_gphkbe
58. Medications that block dopamine receptors, treating psychosis.: Antipsychotics
59. Stimulants that may induce hallucinations.: Amphetamines
60. Mental functions affected in schizophrenia.: Cognitive Symptoms
61. Medications used to treat depressive disorders.: Antidepressants
62. Discussing medication side effects with patients.: Patient Education
63. Medications that stimulate dopamine receptors.: Dopamine Agonists
64. Brain region involved in cognitive processing.: Ventromedial Prefrontal Cortex
65. Facility for urgent mental health assessments.: Psychiatric Emergency Room
66. Failure to achieve remission after multiple treatments.: Antidepressant Resistance
67. Study of brain structures related to behavior.: Neuroanatomy
68. Sensory experiences without external stimuli.: Hallucinations
69. A common side effect of antipsychotic medications.: Tardive dyskinesia
70. Works on dopamine and serotonin neurotransmitters.: Atypical antipsychotic
71. Increase efficacy for treating positive schizophrenia symptoms.: D2 partial agonists
72. May cause apathy and social withdrawal in patients.: Conventional antipsychotic
73. Blocked in the mesolimbic system by certain medications.: D2 receptors
74. Movement disorders caused by antipsychotic medications.: Extrapyramidal symp-
toms (EPS)
75. D2 receptor blockade reduces EPS risk.: Nigrostriatal pathway
76. Believed to improve depression symptoms in patients.: 5HT2 antagonism
77. Possible response to antidepressant monotherapy in bipolar patients.: Hypo-
manic episode
78. Unsustained response to antidepressants noted in patients.: Rapid poop out
79. Contraindicated for antidepressant monotherapy treatment.: Bipolar II designation
80. Include elevated mood, increased energy, and impulsivity.: Manic symptoms
81. Affected by norepinephrine action in depression.: Serotonin levels
82. May indicate reduced SSRI/SNRI treatment response.: S genotype of SERT
83. Include hallucinations and delusions.: Positive symptoms of schizophrenia
84. Include apathy and lack of emotion.: Negative symptoms of schizophrenia
85. Used to treat schizophrenia and mood disorders.: Antipsychotic medications
86. Neurotransmitter targeted by antipsychotic medications.: Dopamine
verified answers ( detailed & elaborated) ACTUAL EXAM 2025 TEST!!
Study online at https://quizlet.com/_gphkbe
1. Patient refusal to follow prescribed treatment.: Noncompliance
2. Disruption in brain chemical levels affecting mood.: Neurotransmitter Imbalance
3. Symptoms that add to the patient's experience.: Positive Symptoms
4. Increased restlessness or anxiety in schizophrenia.: Agitation
5. Neurotransmitter linked to mood regulation.: Serotonin
6. First antidepressant targeting serotonin imbalance.: Prozac
7. Impaired neurotransmitter functions in psychiatric illnesses.: Dysfunctioning Neuro-
transmitter Systems
8. Process of converting genetic information into proteins.: Gene Expression
9. Protein that initiates gene transcription.: Transcription Factor
10. Changes in behavior influencing genetic expression.: Behavior Modification
11. Enzyme system affecting drug metabolism.: Cytochrome P450
12. Amount of drug available after metabolism.: Bioavailability
13. Study of drug absorption, distribution, metabolism, and excretion.: Pharmaco-
kinetics
14. Some Asians require reduced doses of medications.: Lower Drug Doses
15. Receptors that mediate cellular responses to neurotransmitters.: G-Protein Linked
Receptors
16. Medications that block receptor activity.: Antagonistic Traits
17. Medication used for treatment-resistant schizophrenia.: Clozapine (Clozaril)
18. Smoking can alter medication metabolism.: Smoking Impact
19. Mood stabilizer associated with thrombocytopenia.: Carbamazepine (Tegretol)
20. Medication used to treat mood disorders.: Mood Stabilizer
21. Antidepressant also used for chronic pain.: Amitriptyline (Elavil)
22. SSRI antidepressant for depression and anxiety.: Fluoxetine (Prozac)
23. Low platelet count caused by medication.: Drug-Induced Thrombocytopenia
24. An antidepressant used for mood disorders.: Amitriptyline (Elavil)
25. Decreases serotonin and dopamine activity.: Inverse agonist
26. Medications for anxiety and panic disorders.: Benzodiazepines
27. Receptors that mediate rapid synaptic transmission.: Ionotropic receptors
28. Medication used for smoking cessation.: Varenicline (Chantix)
, Test Bank NURS 6630 Midterm Exam (2025) comprehensive questions a
verified answers ( detailed & elaborated) ACTUAL EXAM 2025 TEST!!
Study online at https://quizlet.com/_gphkbe
29. Drugs that partially stimulate receptors.: Partial agonists
30. Medications used to stabilize mood and treat seizures.: Anticonvulsants
31. Channels activated by neurotransmitter binding.: Ligand-gated ion channels
32. An SSRI used to treat panic disorder.: Sertraline
33. Used temporarily to manage anxiety symptoms.: Short-acting benzodiazepine
34. Medications that prevent mood swings in bipolar disorder.: Mood stabilizers
35. Antidepressants with significant food interactions.: MAO inhibitors
36. An SSRI with uncommon sedation side effects.: Fluoxetine
37. Signs of elevated mood and hyperactivity.: Manic symptoms
38. Dopamine receptors targeted by antipsychotics.: D2 receptors
39. Involuntary movements from long-term antipsychotic use.: Tardive dyskinesia
40. Severe increase in blood pressure from food interactions.: Hypertensive crisis
41. Receptors involved in serotonin signaling.: Serotonin 3 receptors
42. Cholinergic receptors that respond to acetylcholine.: Nicotinic receptors
43. Receptors activated by the neurotransmitter acetylcholine.: Cholinergic receptors
44. Inhibitory receptors in the central nervous system.: Glycine receptors
45. Stimulates dopamine receptors to treat Parkinson's disease.: Dopamine agonist
46. Primary binding site for dopamine agonists.: D2 Receptors
47. Pathways influencing cognitive symptoms in schizophrenia.: Mesocorticol Projec-
tions
48. Antidepressant with rare induction of mania.: Fluoxetine
49. Medications requiring avoidance of certain decongestants.: MAO Inhibitors
50. Severe increase in blood pressure from drug interactions.: Hypertensive Crisis
51. Symptoms persisting despite treatment for major depression.: Residual Symptoms
52. Influences response to SSRIs and SNRIs.: SERT Genotype
53. Inability to feel pleasure, common in depression.: Anhedonia
54. Considered a positive symptom of schizophrenia.: Agitation
55. Requires antipsychotics targeting specific symptoms.: Paranoid Psychosis
56. Theory explaining schizophrenia symptoms via dopamine pathways.: Dopamine
Hypothesis
57. Syndrome associated with various psychiatric disorders.: Psychosis
, Test Bank NURS 6630 Midterm Exam (2025) comprehensive questions a
verified answers ( detailed & elaborated) ACTUAL EXAM 2025 TEST!!
Study online at https://quizlet.com/_gphkbe
58. Medications that block dopamine receptors, treating psychosis.: Antipsychotics
59. Stimulants that may induce hallucinations.: Amphetamines
60. Mental functions affected in schizophrenia.: Cognitive Symptoms
61. Medications used to treat depressive disorders.: Antidepressants
62. Discussing medication side effects with patients.: Patient Education
63. Medications that stimulate dopamine receptors.: Dopamine Agonists
64. Brain region involved in cognitive processing.: Ventromedial Prefrontal Cortex
65. Facility for urgent mental health assessments.: Psychiatric Emergency Room
66. Failure to achieve remission after multiple treatments.: Antidepressant Resistance
67. Study of brain structures related to behavior.: Neuroanatomy
68. Sensory experiences without external stimuli.: Hallucinations
69. A common side effect of antipsychotic medications.: Tardive dyskinesia
70. Works on dopamine and serotonin neurotransmitters.: Atypical antipsychotic
71. Increase efficacy for treating positive schizophrenia symptoms.: D2 partial agonists
72. May cause apathy and social withdrawal in patients.: Conventional antipsychotic
73. Blocked in the mesolimbic system by certain medications.: D2 receptors
74. Movement disorders caused by antipsychotic medications.: Extrapyramidal symp-
toms (EPS)
75. D2 receptor blockade reduces EPS risk.: Nigrostriatal pathway
76. Believed to improve depression symptoms in patients.: 5HT2 antagonism
77. Possible response to antidepressant monotherapy in bipolar patients.: Hypo-
manic episode
78. Unsustained response to antidepressants noted in patients.: Rapid poop out
79. Contraindicated for antidepressant monotherapy treatment.: Bipolar II designation
80. Include elevated mood, increased energy, and impulsivity.: Manic symptoms
81. Affected by norepinephrine action in depression.: Serotonin levels
82. May indicate reduced SSRI/SNRI treatment response.: S genotype of SERT
83. Include hallucinations and delusions.: Positive symptoms of schizophrenia
84. Include apathy and lack of emotion.: Negative symptoms of schizophrenia
85. Used to treat schizophrenia and mood disorders.: Antipsychotic medications
86. Neurotransmitter targeted by antipsychotic medications.: Dopamine
